FUJIFILM Wako Pure Chemical will be an authorized agent and distributor for Mawi products in Japan to detect viruses such as COVID-19.
HAYWARD, CA – October 04, 2021 – Mawi DNA Technologies has signed a distribution agreement with FUJIFILM Wako Pure Chemical Corporation, a leader in the biomedical industry, to deliver Mawi’s iSWAB biosampling technologies to Japan.
“The collaboration with FUJIFILM Wako Pure Chemical to provide iSWAB Microbiome-EL sample collection tubes for molecular testing of COVID-19 by PCR and LAMP based assay allows us to offer a valuable solution in the Japanese market,” said Atsushi Yanai, Asia Pacific Business Development at Mawi. “Being able to offer the collection without the need for an RNA Extraction step complements the WAKO Genomics product range, a valuable solution in the Japanese market and to society.”
FUJIFILM Wako Pure Chemical will be an authorized agent and distributor for Mawi products in Japan to detect viruses such as COVID-19.
“We are extremely grateful for the opportunity to partner with FUJIFILM Wako Pure Chemical, a respected organization with access to key customers in the Japanese market,” added Jerome David, VP of Sales and Marketing at Mawi. “We are confident that this initial partnership around our iSWAB-Microbiome-EL technology for extraction-less detection of SARS-CoV-2 RNA in patient samples will lead to additional opportunities for our entire portfolio of biosample collection products.”
About FUJIFILM Wako Pure Chemical Corporation
FUJIFILM Wako Pure Chemical, a subsidiary of FUJIFILM Corporation, is a company providing a wide range of high quality and advanced products including laboratory chemicals, specialty chemicals and clinical diagnostic reagents. Under a mission to create the source of happiness for all people with commitment to the future of science, the company will continue to contribute to the progress of the fields of life sciences and advanced materials by developing and supplying cutting-edge products. For more information, please visit https://www.fujifilm.com/ffwk/en.
Customer Contact:
FUJIFILM Wako Pure Chemical Corporation
Sales Promotion Section
ffwk-labchem-tec@fujifilm.com
About Mawi DNA
Mawi DNA Technologies, founded in 2013, has developed and commercialized the iSWAB technology, an innovative system for collection of biosamples. Mawi’s mission is to uphold sample integrity from anywhere in the world at room temperature, enabling true sample diversity across any geography or population segment. The company’s flagship product iSWAB-DNA is the only sample collection product on the market proven to produce a high quality DNA sample with low bacterial DNA content. Mawi also supplies products for collection of RNA, microbiome, intact cells, and whole blood. At Mawi, The Future of Biosampling is Here™. For more information, please visit http://www.mawidna.com.
Candida Data Using iSWAB In Response to New Infectious Diseases...
A deadly fungal infection, Candida Auris, is becoming a serious threat. This drug-resistant strain is deadly for those with weakened immune systems and is spreading at an alarming rate. The READ MORE
Top Reasons to Ditch Your Current VTM. Upgrade your Viral…...
Mawi DNA has developed iSWAB-RC-EL, an FDA approved sample collection device for transport and storage of samples suspected of containing an infectious disease*. Why iSWAB-RC-EL is the superior op...
READ MOREMawi DNA Announces Dr. Bouzyk as New Board Member!...
It is with great delight and excitement that we announce that Dr. READ MORE